Methotrexate for giant cell arteritis

The objective of this review is to assess the benefits and harms of methotrexate for patients with giant cell arteritis in terms of the following major outcomes: disease relapse, sustained discontinuation of corticosteroids, cumulative dose of glucocorticoids, cranial ischemic complications, health-related quality of life, short term serious adverse effects, and withdrawals due to adverse events.

This is a protocol.